Trademarkia Logo

Canada

C$
Trademark Search in Canada
MIRTH CONTROL

View On IC.GC.CA

MIRTH CONTROL
ABANDONED SECTION 36

on 5 Apr 2023

Last Applicant/ Owned by

ETHAN S. ERNEST

2850 SW Cedar Hills Blvd #425Beaverton, OR 97005

US

Serial Number

1797594 filed on 25th Aug 2016

Correspondent Address

GOODMANS LLP

ATTN: INTELLECTUAL PROPERTY GROUPBAY ADELAIDE CENTRE333 BAY STREET, SUITE 3400TORONTO

ONTARIO

CA

M5H2S7

MIRTH CONTROL

Trademark usage description

medical marijuana and medical cannabis, and marijuana and cannabis in the form of pills, capsules, sublingual doses, mucous membrane doses, and edible Read More

Classification Information

Class [005]
Medical marijuana and medical cannabis, and marijuana and cannabis in the form of pills, capsules, sublingual doses, mucous membrane doses, and edibles namely gummies and chewing gum all for the relief of pain and treatment in palliative care, for reducing stress and fatigue, for mood enhancement, for relief from nausea, vomiting, headaches, muscle spasms, seizures, wasting syndrome and loss of appetite in AIDS and cancer patients, for maintaining general health and well-being, for treating symptoms associated with anorexia nervosa, Crohn's disease, multiple sclerosis, amyotrophic lateral sclerosis, fibromyalgia, spinal cord injury, epilepsy, migraines, arthritides and musculoskeletal disorders, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, rheumatism, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, epilepsy, convulsant and movement disorders, cervical dystonia, Meige's syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, attention and hyperactivity disorders, Alzheimer's disease, and dementia, for the treatment of, and symptoms associated with, skin infections and irritations, namely bacterial skin infections, dermatitis, atrophie blanche, eczema, burns, rashes from skin allergies and reactions, psoriasis, pruritis and neuropathic pain, for the treatment of, and relief of symptoms associated with, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, Wilson's disease, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis, osteoarthritis, and osteoporosis, and all the aforementioned products as anti-inflammatories, anti-viral enzyme activators, analgesics, sedatives, appetite stimulants and anti-emetics, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antibacterials, antidepressants and antihypertensives.

Classification kind code

10

Class [029]
Prepared marijuana seeds for human consumption.

Classification kind code

10

Class [030]
Cannabis-infused fruit-jelly candy and chewing gum.

Classification kind code

10

Class [034]
Dried cannabis and cannabis for recreational purposes in the form of pills, capsules, sublingual doses, and mucous membrane doses.

Classification kind code

10

Class [038]
Providing access to a website providing information in the field of marijuana and cannabis.

Classification kind code

10

Class [041]
Providing educational information in the field of marijuana and cannabis via a website.

Classification kind code

10

Mark Details

Serial Number

1797594

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 15
on 28th Feb 2020		Correspondence Created
Submitted for opposition 15
on 7th Nov 2019		Correspondence Created
Submitted for opposition 15
on 16th Oct 2018		Correspondence Created
Submitted for opposition 15
on 6th Nov 2017		Correspondence Created
Submitted for opposition 12
on 25th Sept 2017		Extension of Time
Submitted for opposition 22
on 14th Mar 2017		Search Recorded
Submitted for opposition 20
on 14th Mar 2017		Examiner's First Report
Submitted for opposition 1
on 26th Aug 2016		Created
Submitted for opposition 31
on 26th Aug 2016		Formalized
Submitted for opposition 30
on 25th Aug 2016		Filed